Advocacy intelligence hub — real-time data for patient organizations
ThyroShield: FDA approved
For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance2
ThyroShield
Fleming & Company, Pharmaceuticals
AZACITIDINE
Pilnova Pharma Inc
Reblozyl
(LUSPATERCEPT)Orphan drugstandardCelgene Corporation
Browse all Acute myeloid leukemia and myelodysplastic syndromes related to radiation news →
Amanda Olson
M.D. Anderson Cancer Center
Nancy A. Kernan, MD
Memorial Sloan Kettering Cancer Center
📍 NEW YORK, NY
View all Acute myeloid leukemia and myelodysplastic syndromes related to radiation specialists →